J. Warren Huff

2019

In 2019, J. Warren Huff earned a total compensation of $5.5M as Chief Executive Officer, President and Chairman of the Board at REATA PHARMACEUTICALS, a 493% increase compared to previous year.

Compensation breakdown

Bonus$600,540
Option Awards$4,346,850
Salary$578,500
Other$16,715
Total$5,542,605

Huff received $4.3M in option awards, accounting for 78% of the total pay in 2019.

Huff also received $600.5K in bonus, $578.5K in salary and $16.7K in other compensation.

Rankings

In 2019, J. Warren Huff's compensation ranked 1,910th out of 13,971 executives tracked by ExecPay. In other words, Huff earned more than 86.3% of executives.

ClassificationRankingPercentile
All
1,910
out of 13,971
86th
Division
Manufacturing
689
out of 5,701
88th
Major group
Chemicals And Allied Products
211
out of 2,200
90th
Industry group
Drugs
169
out of 1,886
91st
Industry
Pharmaceutical Preparations
126
out of 1,398
91st
Source: SEC filing on April 29, 2020.

Huff's colleagues

We found five more compensation records of executives who worked with J. Warren Huff at REATA PHARMACEUTICALS in 2019.

2019

Manmeet Soni

REATA PHARMACEUTICALS

Chief Financial Officer

2019

Colin Meyer

REATA PHARMACEUTICALS

Chief Medical Officer

2019

Jason Wilson

REATA PHARMACEUTICALS

Executive Vice President, Operations

2019

Michael Wortley

REATA PHARMACEUTICALS

Chief Legal Officer

2019

Dawn Bir

REATA PHARMACEUTICALS

Chief Commercial Officer and Executive Vice President

News

In-depth

You may also like